Introduction
Treatment of musculoskeletal injuries is still demanding, because most of these tissues have low healing capability and are under different forces during healing and regeneration. Tissue engineering is one of the new approaches aimed to solve these difficulties. Simply, tissue engineering could be divided into three parts: scaffolds, healing promotive factors and stem cells. Healing promotive factors such as growth factors and a wide variety of glycosaminoglycans have major roles in the healing process of connective tissues; however, most of the tissue-engineered products are expensive and may not be available at the time of treatment. Synovial fluid is an available option, and it contains different healing promotive factors mainly glycosaminoglycans and lubricin. The major glycosaminoglycans that have been found in synovial fluid of different species are hyaluronic acid and chondroitin sulphate that have been shown to be effective in reducing peritendinous adhesion and inflammation. They also can modulate different stages of wound healing by motivating the healing cells to deposit more matrix and collagen fibres and have some antioxidant and protective effects, which promote efficient wound healing. This review has focused on the roles of these glycosaminoglycans on different musculoskeletal injuries in vitro, in vivo and in clinical situations. Due to the availability of hyaluronic acid and chondroitin sulphate in normal synovial fluid, it is reasonable to suggest the synovial fluid as a new treatment strategy in musculoskeletal medicine and surgery. Synovial fluid can be obtained from auto-, allo-and xenogeneic bases. The xenogeneicbased synovial fluid is more available than the other two forms. It is recommended to make some processing such as acellularization, sterilization and purification before application of the synovial fluid. Based on this evidence, it seems the exogenous synovial fluid could be considered as a popular therapeutic agent in the near future. The aim of this review was to discuss exogenous synovial fluid as a new option in tissue engineering.
Conclusion
Glycosaminoglycans such as hyaluronic acid and chondroitin sulphate make up the synovial fluid. Hyaluronic acid is beneficial in reducing peritendinous adhesion and signs of osteoarthrosis and in improving bone tunnel healing, tendon and bone regeneration. Exogenous synovial fluid looks to be a good method of providing glycosaminoglycans to the site of injury. We call on further studies to increase our understanding of synovial fluid and the effectiveness of its compounds in different injured tissues.
Introduction
Treatment of soft and hard connective tissues is still challenging 1 . Based on the nature of the injury, different healing responses occur and accordingly different healing pathways are activated 1 . In general, after injury, coagulation and inflammation occurs in the injured area 1 . Several inflammatory cells such as neutrophils, macrophages, lymphocytes and plasma cells infiltrate the injured area; degrade the remaining necrotic tissues and deliver growth factors, cytokines and proinflammatory mediators 1, 2 . Growth factors such as basic fibroblasts growth factors, vasculoendothelial growth factor, platelet-derived growth factors and tissue growth factor beta have significant roles in motivating the migrating mesenchymal cells to produce sufficient tissue matrix [2] [3] [4] [5] . Complicated events happen in the inflammatory phase of healing, and several factors can influence this stage of tissue healing 6 . In an optimum inflammation, the concentration of the growth factors and proinflammatory cytokines increases, and this results in higher cellularity and deposition of higher matrix, which has a significant role in the final outcome of the healing tissue [7] [8] [9] [10] [11] . During the stage of matrix deposition, the non-sulphated glycosaminoglycans such as hyaluronic acid (HA) are deposited first 7 . This glycosaminoglycan acts as a scaffold for collagen deposition and provides an optimum environment for cell proliferation, differentiation and maturation 6 . Whenever the HA increases, the inflammatory response decreases, and this indicates that the healing response is shifted from the inflammatory to fibroplasia stage 7 . The concentration of this glycosaminoglycan then gradually decreases, and this reduction is parallel to enhanced collagen deposition and elevated concentration of chondroitin sulphate (CS) and other
• Shock absorption-as a dilatant fluid, synovial fluid is characterized by the rare quality of becoming more viscous under applied pressure; the synovial fluid in the diarthrotic joints becomes thick the moment shear is applied in order to protect the joint and subsequently thins to normal viscosity instantaneously to resume its lubricating function between shocks 16 .
• Nutrient and waste transportation-the fluid supplies oxygen and nutrients, removes carbon dioxide and metabolic wastes from the chondrocytes within the surrounding cartilage. Thus it helps the joint hemosthasis 18, 19 .
What is the composition of synovial fluid?
Normal synovial fluid contains 3-4 mg/mL hyaluronan (HA), a polymer of disaccharides composed of D-glucuronic acid and D-N-acetylglucosamine joined by alternating beta-1,4 and beta-1,3 glycosidic bonds 16 . Hyaluronan is synthesized by the synovial membrane and secreted into the joint cavity to increase the viscosity and elasticity of articular cartilages and to lubricate the surfaces between synovium and cartilage. Synovial fluid also contains CS, a polysulphated glycosaminoglycan, which has substantial roles in cell regulation and joint structure. CS is the most important joint component. The proportion of HA/CS in a normal synovial fluid is about 93/7%. This proportion is quite different between human and different species of animals and also between the individuals. Synovial fluid contains lubricin secreted by synovial cells 17 . Chiefly, it is responsible for the so-called boundary-layer lubrication, which reduces friction between opposing surfaces of cartilage 18, 20 . There are also some evidences that show it helps in regulating synovial cell growth 20, 21 . The function of lubricin is to reduce friction by lubricating on their beneficial effects on wound healing 11 . Based on the above explanations, this review was designed to introduce the exogenous synovial fluid as a potential treatment regimen; we also reviewed the effectiveness of its compounds in different injured tissues. Because most of the synovial fluid's glycosaminoglycans are HA and CS, we focused on these two glycosaminoglycans. The concepts presented in this review may be valuable for those researchers and practitioners who have concerns about wound healing and regeneration.
What is synovial fluid?
Synovial fluid is a viscous, non-Newtonian fluid found in the cavities of synovial joints 16 . It can be obtained from humans and different species of animals. The major characteristics of the synovial fluid are its viscoelastic properties (yolk-like consistency), which have a principal role in reducing friction between the articular cartilages of synovial joints during movement 17 . The inner membrane of synovial joints secretes synovial fluid into the joint cavity 18 . The fluid mainly contains HA and to a lesser extent CS and is secreted by the synovial fibroblast in the synovial membrane and the interstitial fluid filtered from the blood plasma 16 . This fluid forms a thin layer (roughly 50 µm) at the surface of the articular cartilage and also seeps into microcavities and irregularities in the cartilage surface, filling all empty spaces 19 . The fluid in articular cartilage effectively serves as a synovial fluid reserve. During movement, the synovial fluid held in the cartilage is squeezed out mechanically to maintain a layer of fluid on the cartilage surface (so-called weeping lubrication). The functions of the synovial fluid include:
• Reduction of friction-synovial fluid lubricates the articulating joints 17 . This minimizes the wear and tear and helps the joint to be healthy during movement. polysulphated glycosaminoglycans 1, 6 . CS has an important role in the differentiation of collagen fibrils by increasing the transverse diameter of the newly regenerated fibrils 6, [12] [13] [14] . By shifting the fibroplasia to remodelling stage, the collagen content of the tissue approximates its peak level but the concentration of the glycosaminoglycans diminishes 13, 15 . Therefore, it can be suggested that although the unsulphated and polysulphated glycosaminoglycans are effective at different stages of wound healing, their major role is in the inflammatory and fibroplasia stage of wound healing, and treatment modalities using glycosaminoglycans should administer them at the early phases of wound healing 14 
.
Tissue engineering is one of the newest options in managing tissue injuries 11 . In the last decade, several advancements have been achieved by tissue-engineering technologies in producing novel biomaterials effective in tissue healing 11 . Tissue engineering is divided into three categories. The first category has mainly focused on the production of tissue scaffolds with the aim to be a tissue conductor and guide the healing tissue in a desired anatomical orientation 1 . The second category is well matched with those healing promotive agents such as platelet-rich plasma, growth factors and glycosaminoglycans 1, 2 . These promotive factors have significant roles in cell proliferation, matrix deposition and remodelling of the healing tissue [2] [3] [4] [5] . Scaffolds can be used as carriers of these therapeutic compounds in order to deliver them at different stages of wound healing 1 . The third category belongs to the stem cells. Stem cells can be seeded on the scaffolds or can be directly injected into the injured area. Increase in mesenchymal cellularity in the injured area could result in higher matrix deposition. is not absolute, and some proteoglycans have both structural and regulatory roles 38 . CS is a major component of the extracellular matrix and is important in maintaining the structural integrity of the tissue 38 . This function is typical of the large aggregating proteoglycans: aggrecan, versican, brevican and neurocan, collectively termed the lecticans 37, 39 . As part of aggrecan, CS is a major component of cartilage 38 . The tightly packed and highly charged sulphate groups of CS generate electrostatic repulsion that provides much of the resistance of cartilage to compression. Loss of CS from the cartilage is a major cause of osteoarthritis 34, 35 . CS readily interacts with proteins in the extracellular matrix due to its negative charges. These interactions are important for regulating a diverse array of cellular activities 37 .
Chondroitin is in dietary supplements used as an alternative medicine to treat osteoarthritis and also approved and regulated as a symptomatic slow-acting drug for this disease (SYSADOA) in Europe and some other countries 36 . It is commonly sold together with glucosamine 36, 40 . Chondroitin and glucosamine are also used in veterinary medicine 41 . The dosage of oral chondroitin used in human clinical trials is 800-1,200 mg/day 36, 40, 42 . Most chondroitin appears to be made from extracts of cartilaginous cow and pig tissues (cow's trachea and pig's ear and nose), but other sources such as shark, fish and bird cartilage are also used 39, 40 . Since chondroitin is not a uniform substance, and is naturally present in a wide variety of forms, the precise compositions of each supplement will vary 42 . The effects of CS in patients with osteoarthritis are likely to result in a number of reactions including its anti-inflammatory activity, stimulation of proteoglycans and HA synthesis and decrease in catabolic activity of chondrocytes which inhibits synthesis of proteolytic enzymes, nitric with hyaluronan-mediated motility receptor, which has been implicated in developmental processes, tumour metastasis and pathological reparative processes 21, 31 . Fibroblasts, mesothelial cells and certain types of stem cells surround themselves in a pericellular 'coat', part of which is constructed from hyaluronan, in order to shield themselves from bacteria, red blood cells or other matrix molecules 29, 32 . For example, with regard to stem cells, hyaluronan, along with CS, helps to form the stem cell niche. Stem cells are protected from the effects of growth factors by a shield of hyaluronan and minimally sulphated CS. During progenitor division, the daughter cell moves outside of this pericellular shield where it can then be influenced by growth factors to differentiate even further 30, 33 .
What is CS?
CS is a sulphated glycosaminoglycan composed of a chain of alternating sugars (N-acetylgalactosamine and glucuronic acid) 6, [12] [13] [14] . It is usually found attached to proteins as part of a proteoglycan 7 . A chondroitin chain can have over 100 individual sugars, each of which can be sulphated at varying positions and quantities 34, 35 . CS is an important structural component of cartilage and provides much of its resistance to compression. It has excellent water uptake, water binding and delivery characteristics and its water absorption rate is high. CS by this effect increases the thickness of articular cartilages and helps them to be healthy during movement and functionality. Along with glucosamine, CS has become a widely used dietary supplement for treatment of osteoarthritis 36 . However, this dietary supplement is not a drug 37 . Chondroitin's functions depend largely on the properties of the overall proteoglycan of which it is part of 38 . These functions can be broadly divided into structural and regulatory roles 39 . However, this division the joint, absorbing shocks and supplying oxygen and nutrients to and removing carbon dioxide and metabolic wastes from the chondrocytes within articular cartilage. It also contains phagocytic cells that remove microorganisms and the debris that results from normal wear and tear in the joint 17, 18, 20 .
What is HA?
HA is a major component of synovial tissues and fluid, as well as other soft tissues, which is responsible to endow their environments with remarkable rheological properties 22 .
Solutions of HA are known to be viscoelastic, and viscosity changes with sheer stress 6, 23 . At low sheer stress, a solution of 10 g/L of HA may have a viscosity 10 6 times the viscosity of the solvent, while under high sheer stress, viscosity may drop by as much as 10 3 times 11, 24 . The aforementioned rheological properties of solutions of HA make it ideal for lubricating joints and surfaces that move along each other, such as cartilage and intrasynovial flexor tendons 21, 25, 26 . In vivo, HA forms hydrated coils that form randomly kinked coils that entangle to form a network 23, 27 . Hyaluronan networks retard diffusion and form a diffusion barrier that regulates transport of substances through intercellular spaces. Hyaluronan takes part in the partitioning of plasma proteins between vascular and extravascular spaces, and it is this excluded volume phenomenon that affects the solubility of macromolecules in the interstitium, changes chemical equilibria and stabilizes the structure of collagen fibers 28, 29 . Other functions include matrix interactions with hyaluronan-binding proteins such as hyaluronectin, glial hyaluronan-binding protein, brain-enriched hyaluronanbinding protein, collagen VI, TSG-6 and inter-alpha-trypsin inhibitor 23, 30 . Cell-surface interactions involving hyaluronan have a well-known coupling with CD44, which may be related to tumour progression, and also 36, 38, 40 . Recently, new mechanisms of action have been described for CS. In an in vitro study, CS reduced the IL-1β-induced nuclear factor-kB translocation in chondrocytes 38 . In addition, CS has been shown to have a positive effect on osteoarthritic (OA) structural changes that occur in the subchondral bone 34, 35 .
What is the lubricin?
Proteoglycan 4 or lubricin is a protein that acts as a joint/intimal cell lubricant. Lubricin is present in synovial fluid and on the superficial layer of articular cartilage and plays an important role in joint lubrication and synovial homeostasis 20, 21 . Lubricin is proinflammatory cytokines such as IL-6 and PGE2 production 34,38 (Table 1). Effects of HA on different population of fibroblasts have also been tested in vitro 28, 30, 46, 47 . HA has been shown to inhibit cell proliferation, promote cell migration, decrease gene expression of proinflammatory cytokines such as COX-2 and PGE2 and increase the expression of collagen molecules in the cultured medium. Researches in this area have suggested that due to these mechanisms HA may decrease the peritendinous adhesions 28, 30, 46, 47 . Lippiello et al. 35 tested the role of CS and glucosamine (a glycosaminoglycan) on ligament, tendon and cartilage cells. They showed that CS improved the production of collagen and non-collagen proteins in tendon and ligament cells. It also modulated the inflammatory cytokines and increased cell viability in vitro (Table 1) .
Lajeunesse et al. 48 showed that the high molecular weight of HA can decrease osteocalcin, PGE-2 and IL-6 in human OA subchondral osteoblasts. Hegewald et al. 18 showed that HA and synovial fluid differentiated the mesenchymal stem cells to chondroblasts and increased chondroblast proliferation in vitro. In another study, Tsai et al. 19 showed that treatment with human synovial fluid can increase osteoblast proliferation and growth. It also increased collagen and bone production in cultured osteoblasts, in vitro. Kawano et al. 32 used various concentrations of HA on osteoblasts and showed that HA promoted differentiation in these cells. Wodewotzky et al. 29 showed that HA can improve cell viability and increases cell proliferation in bone marrow-derived canine mesenchymal stem cells in vitro. Wu et al. 49 showed that these beneficial effects Competing interests: none declared. Conflict of interests: none declared.
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are correlated with the molecular weight of HA and high-molecularweight HA increased cell migration and growth and prevented cell death in human corneal epithelial cells in vitro ( Table 1) . The effect of HA on tissues has also been investigated in vitro. Wiig et al. 25 showed that HA can modulate cell proliferation unequally in intraand extrasynovial tendons without affecting the synthesis of matrix components in vitro. Several in vitro tests also investigated the role of HA on tendon gliding resistance. Almost all of these in vitro investigations showed that various concentrations of HA can reduce gliding resistance of the tendons. This characteristic of HA is very important in tendon healing because it is believed that HA can improve tendon mobility after injury, and this may have a role in reducing peritendinous adhesion 21, 26, 31, 50, 51 (Table 1). Henson et al. 33 showed that a combination of HA, CS and glucosamine can interestingly increase the number of repair cells and decrease the number of apoptotic cells. This suggested that the combination of these glycosaminoglycans produces a superior effect than each one alone.
Roles of the synovial fluid glycosaminoglycans in animal studies Rabbit Rabbits are one of the best animal models for orthopaedic researches. They are easy to handle, and their body conformation gives an opportunity to design any injury and treatment modalities. They are also inexpensive compared with dogs, sheep and horse and have many similarities to humans. For these reasons, most of the in vivo animal studies have selected rabbits as an animal model 2 . Here we have discussed the role of synovial fluid glycosaminoglycans in a rabbit model.
The role of HA in tendon healing has been previously reported by many studies 6, 7, 22, 24, 27, [52] [53] [54] [55] [56] [57] [58] . Most investigators showed that HA and to a lesser extent CS have a strong role in reducing tendon adhesion in vivo 6,7,22,52,56 ( Table 2 ). Some others showed that HA not only has roles in reducing peritendinous adhesion but also has some advanced roles in the tendon healing process. It has been shown that HA increases VEGF and collagen expression and collagen production in vivo. HA also significantly increased the structural (Table 2) . In two recent studies by Oryan et al. 6, 7 , a better description for the role of HA on tendon healing has been presented. They showed that repeated administration of highmolecular-weight sodium HA with or without CS reduced cell proliferation in peritendinous tissues and thus inhibited the peritendinous adhesion in the injured treated tendons compared with those of the control ones at 28 and 84 days after injury. They showed that HA reduced the clinical signs of inflammation and resulted in reduced transverse diameter of the injured area in rabbits. They showed that HA preserved some of the large collagen fibrils in the injured area at the ultrastructural level, and these collagen fibrils acted as a scaffold for the newly regenerated collagen fibrils. HA also significantly increased fibrillogenesis and the diameter of the newly regenerated collagen fibrils and therefore increased the collagen density. Treated lesions with HA were more aligned, and their biomechanical properties were significantly higher than those of the untreated ones (Table 2) .
HA has not only shown to be effective in tendon healing but also has some beneficial roles on the tendon to bone healing. This is very important in ACL reconstructive surgery where the graft should be incorporated with the bony tunnel, and a role of HA in this regard should be highlighted. Li et al. 58 showed that HA enhanced new bone formation at the junction between bone tunnel and artificial graft in rabbits ( Table 2) .
One of the applications of HA is in the field of biomaterials and tissue engineering. HA can be produced as a membrane applicable in tendon injuries. Such an application was designed to reduce tendon adhesion. Zuo et al. 59 showed that HA as a bidimensional membrane is effective in reducing tendon adhesion in rabbits.
Their model of tendon injury was a simple flexor tendon transection model that was repaired surgically and the HA membrane was wrapped around the injured area. This method of application has major clinical relevance and should be appreciated. HA has also been shown to be effective in wound healing in rabbits 60, 61 ( Table 2 ). In a wound defect model in rabbits, it has been shown that the application of HA in combination with fibrin or xenogeneic based dermal matrix is an effective method to improve re-epithelialization, angiogenesis, collagen alignment, collagen type I and III production, wound contracture and vascularity 60, 61 . Effects of HA on osteoarthrosis have been investigated in rabbits. Duygu et al. 62 showed that three times administration of intra-articular HA is effective in decreasing cartilage changes and HA is a strong chondroprotective agent (Table 2) .
CS as another synovial fluid glycosaminoglycan has been shown to also tested the role of HA injection in the healing supracoracoid tendon laceration model in chicken and indicated that HA caused the earlier restoration of continuity in the lacerated site of the supracoracoid tendon and increased procollagen, TGF-β and bFGF expression. Yagi et al. 74 in a partial flexor tendon-severing model in chicken preserved tenosynovium in one group and discarded tenosynovium in another group and showed that tenosynovium has a significant role in reducing peritendinous adhesion, and this effect is mainly due to HA production (Table 3) .
Dog
Canines are the best animal models when the results aim to be translated into human clinical trials, because their anatomic characteristics are very similar to humans and handling them is easy. In addition, due to the larger body size, every injury and treatment modality can be designed and performed. The results of the canine-based studies could be well translated both in humans and in veterinary medicine, and this is the major merit of canine-based studies.
Tanaka et al. 75 created a tendon defect model and reconstructed it with a peroneus longus tendon. They modified their graft surface with carbodiimide-derivatized HA and gelatin and indicated that HA reduced tendon adhesion at the gross level but did not have any effect on tendon healing or the biomechanical properties of the healing tissues. In another study, Zhao et al. 76 used the same injury and treatment modality and indicated that surface modification with HA improves digital function and tendon gliding ability in dogs. Zhao et al. 20 with a similar methodology showed that surface modification with HA eliminated graft adhesions and improved digit function in dogs (Table  3) . One of the potential factors that can explain these controversies is the molecular weight of HA. It seems that can significantly reduce peritendinous adhesion and improve tendon healing in an Achilles tendinitis model in rats. Roth et al. 68 also tested the efficacy of high-molecular-weight HA on antigen-induced arthritis in rats and suggested that HA can reduce proteoglycan loss and inflammation and prevent cartilage damage in the short term. However, they stated that HA was not effective in the long term; so the treated and control lesions showed no significant differences. HA has been shown to be effective in bone healing. Three studies tested the effectiveness of tissue-engineeredbased HA on bone healing. Kim et al. 69 suggested that HA hydrogel can be used as a carrier for bone morphogenic protein and stem cells so that they assembled bone morphogenic protein and stem cells in HA hydrogel and used it to treat the clavarial defect model in rats. They concluded that HA was able to increase the rates of bone regeneration. Patterson et al. 70 in a similar study and design approved the results of Kim et al. 69 in rats. Finally, de Brito Bezerra et al. 71 combined HA gel with collagen sponge and implanted this hybrid scaffold in a critical-size calvarial defect in rats and showed that HA increases new bone formation (Table 3) .
Chicken
Chicken is one of the most inexpensive animals with characteristics similar to rabbits. However, it should be remembered that rabbits are the more valuable animal models because in comparison with chickens, their anatomic variations are more similar to humans. Also, most of the researches have been performed in rabbits, and therefore, results of rabbit-based studies could better be compared than those of chickenbased studies 2 . Ozgenel et al. 72 showed that a single injection of HA into the tendon sheath can be effective to significantly reduce peritendinous adhesion in a simple transection model of tendon have some beneficial effects in different injuries. Gilbert et al. 37 produced a hydrogel form of CS and used it in treating maxillary sinus wound defects in rabbits. They stated that CS improved collagen production and accelerated wound healing. As was discussed, CS is available in clinical practices as an oral supplement. Largo et al. 63 used oral administration of CS to treat chronic arthritis in rabbits. They stated that CS reduces the inflammatory response of the synovial membrane and decreases the synovial histopathological lesions. Kamarul et al. 39 also tested the role of CS on articular cartilage defect in the femoral medial condyle in rabbits. They showed that CS increased Glycosaminoglycans (GAGs) and collagen type II production in the defect area and resulted in significant improvement in the quality of the healing tissue (Table 2) .
Rat
Rat is another animal model that has been widely used in orthopaedic researches. Perhaps rat is not a good animal model, but due to its low cost, this animal model is really popular 2 . Sasaki et al. 64 perforated mid-diaphysis of cortical bones of femurs and injected high-molecular-weight HA in the canal; this indicated that HA gel increased new bone formation and also differentiated the mesenchymal cells. In another study, Trabucchi et al. 65 tested the effects of low-to-moderate molecular weight HA on the wound defect model and suggested that HA was able to increase the rate of wound contraction and reduced oxygen-free radicals. They suggested that HA can act as a scavenger of free radicals. Tuncay et al. 66 also tested the effectiveness of HA on Achilles tendon injury after a simple transection in tendon and indicated that HA neither improved tendon healing nor reduced peritendinous adhesion in a rat model. In another study, Tatari et al. 67 showed that repeated administration of high-molecular-weight HA Competing interests: none declared. Conflict of interests: none declared. high-molecular-weight HA is more effective in reducing tendon adhesion.
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Pig
Pig is not a popular animal model. However, its orthopaedic structures such as tendon and ligaments give this opportunity to design much better injury models than rabbits and rats; however, due to lack of pigbased studies, comparison between their results with the results of other animal model studies is quite hard 2 . Cho et al. 77 used surface coating with HA to modify the surface of the artificial graft. They compared this method with unmodified artificial graft in ACL reconstruction. Their results indicated that HA was able to improve osseointegration within the bone tunnel (Table 3) .
Sheep
Orthopaedic structures of sheep provide the facility to design better models of injury and repair 2 . Aebli et al. 78 coated hydroxyapatite with HA and filled the cancellous bone defect in sheep and indicated that bone-implant contact and interface shear strength were improved by HA. In another study, Schneiders et al. 41 induced experimental tibial bone defects and filled it with hybridized hydroxyapatite/collagen/CS and indicated that CS increases bone formation and osteopontin-positive osteoblasts (Table 3) .
Horse
Horse is one of the most clinically referred animals in veterinary practice, and for this reason, horse-based studies are best suited for the field of veterinary medicine. As an experimental model, they are very expensive and are not suggested for the researches 2 . Gaughan et al. 79 injected HA in the tendon sheath to treat the deep digital flexor tendon tendinitis in clinically ill horses and showed that HA reduces inflammatory cells, decreases adhesion and improves the quality of the healing tendons histologically, but it was not able to increase the biomechanical properties of the repaired tendons. Foland et al. 80 injected HA in the sheath of superficial digital flexor tendon in horses and showed that HA injection is not an effective method in tendon healing. Recently, Marsh et al. 97 injected HA into the navicular bursa to test if HA is effective in reducing navicular syndrome and indicated that HA therapy improved lameness and clinical imaging scoring in horses (Table 3) .
Human clinical studies
In vitro and in vivo studies are used to define whether a treatment modality is effective to be generalized into a human clinical situation. Such a treatment modality should be first tested in vitro, and if the results are encouraging, then it should be tested in different animal species. If the treatment is effective in animal studies and several researches support the beneficial effects of such a treatment modality, then it should be tested in clinical practice. Clinical studies have this merit that they can be conducted in different modalities such as in retrospective and prospective. Their long-term follow up increases the impact of such clinical studies. However, testing a treatment protocol in one human clinical trial study does not guarantee its usage in a wide range of the population as a gold standard. Several reviews and meta-analysis studies are needed to compare different clinical trial results in a wide range of population to suggest if the treatment modality is effective or not 2 . Many orthopaedic injuries are associated with wound injuries, and for this reason treatment of wound injuries is important. Some animal studies have suggested the effectiveness of HA on wound healing (Tables  2 and 3 ). Dalla Paola et al. 81 reported that HA-based scaffold improved wound contracture and repair in one human patient (Table 4) .
Anterior cruciate ligament injury is one the most prevalent orthopaedic injuries in human and animals. Direct treatment of the torn ACL is not recommended because no proper healing occurs, and therefore reconstructive techniques are gold standard methods. Some animal studies also suggested the effectiveness of HA on ACL reconstruction and bone tunnel healing (Tables 2 and 3) . Huang et al. 82 in a controlled clinical trial study showed that weekly intraarticular injection of HA for 3, 4, 8 and 12 weeks improved the clinical scores including changes in Lysholm knee scoring scale, knee range of motion, ambulation speed, muscle peak Competing interests: none declared. Conflict of interests: none declared.
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affected the impact of their study. For example, their major method of assessment was clinical scoring and their follow up time was 3 weeks. These items should be considered when their encouraging results are going to be discussed or compared with other studies. In another study, Chou et al. 84 treated the rotator cuff lesions without complete tears, with repeated administration of high-molecular-weight HA and showed that HA improved the clinical outcome after 5 weeks. However, their follow-up area is under tension, it is important to improve tendon healing. Some animal studies have suggested the effectiveness of HA on tendon healing and peritendinous adhesion (Tables 2 and 3). Costantino et al. 83 in a case series study treated the rotator cuff tears with three infiltrative doses of moderate-to-high-molecular-weight HA (MW: 800-1,200 kDa) and showed the beneficial effects of HA on pain, range of motion and autonomy. However, some issues were present in their study that potentially torque of knee flexion and extension in patients who underwent ACL reconstruction with patellar tendon autograft. The merit of their study was that their follow-up was long term (1 year after treatment), but their major method of assessment was clinical scoring that could be associated with some bias (Table 4) .
Treatment of tendon injuries is challenging. Due to the low healing capability of the tendons and development of peritendinous adhesion and also because the healing time was short, and their method of assessment was based on clinical scoring that altered the impact of their study. In another study, Ozgenel et al. 85 injected three times HA in zone-II flexor tendon injury of the index fingers and indicated that HA was effective in improving range of motion and reducing postoperative tendon adhesion. These results were in accordance with those animal studies that suggested the anti-adhesion effects of HA in tendon healing (see Table 2 ). Muneta et al. 86 in a retrospective study treated patients with patellar tendinopathy with HA injection and indicated that 54% of the cases were able to return to their previous athletic activities with minimum difficulty (Table 4) .
Bone injuries are another orthopaedic situation that should be considered. Bony structures tolerate different forces during healing, and due to the unique mechanisms of bone healing, several complications such as malunion, non-union or infection may occur. Therefore, the rate and quality of bone healing should be improved and the role of glycosaminoglycans should be highlighted in this regard. Some animal studies have suggested the effectiveness of HA on bone healing (Tables 2 and 3 ). Baldini et al. 87 in a controlled clinical trial study treated the postextractive bone defects with high-molecular-weight HA and autologous bone and suggested that HA increases angiogenicity and remodelling of the repair site. They evaluated the lesions with clinical and histological methods and described the positive effects of HA in bone healing (Table 4) .
Osteoarthritis or osteoarthrosis is a degenerative disease of articular cartilages. Treatment of osteoarthritis is extremely hard, and most of the treatment modalities are only palliative rather than curative. Due to the high prevalence of this disease and lack of an established treatment modality, many researches focused on this disease. Some animal studies have suggested the effectiveness of HA and CS on osteoarthrosis. Möller et al. 42 in a placebo-controlled clinical trial study suggested that oral administration of CS for 3 months reduces pain and improves plantar psoriasis in patients with knee osteoarthrosis. The major limitations of their study were that their follow-up time was only 3 months and their methods of assessment were only based on clinical scoring. Such limitations should be considered when their results are going to be discussed and compared with other studies. In another controlled trial study, Swięchowicz et al. 88 followed up OA patients treated with intra-articular injection of a single dose of HA and indicated that HA improves blood antioxidant parameters and clinical outcomes. One of the major merits of their study was that the number of cases in their studies was more than 100 patients, but their follow-up time was short term. In another controlled trial study with higher population, Strand et al. 89 followed the OA patients treated with a single dose of HA for 13 weeks and suggested that HA reduces pain and OA signs. Berenbaum et al.
90
, in another controlled trial study with 769 patients who used low-to-moderate dose of HA, suggested that moderate-molecular-weight HA was more effective in reducing signs of osteoarthrosis than the lower one. They followed up their patients for more than 6 months. In another controlled trial study, DeCaria et al. 91 showed that three weekly injections of HA were not effective in reducing OA signs. One of the major limitations of their study was that the study population was only 30 patients, and therefore this can affect the outcome of the study. Huang et al. 92 in another controlled trial study on 200 patients showed that 5 weekly injections of HA were effective in reducing pain and OA signs. Pavelka and Uebelhart 16 in another controlled trial study on 381 patients showed that 3 weeks injection of highly purified HA reduced signs of osteoarthrosis (Table 4) .
HA has been mainly used in cosmetic medicine. Brandt et al. 93 in a prospective open-label study injected small gel particle HA to find out if HA therapy is effective in improving the signs of moderate-to-severe vascular, bony and tendon prominence in the hand. After 2 weeks, some significant improvement was observed, and they suggested that HA is a safe method in cosmetic medicine and is well tolerated by patients (Table 4) .
CS as another glycosaminoglycan, found in synovial fluid, has been shown to have some roles in reducing signs of osteoarthrosis; however some controversies exist. Sawitzke et al. 36 , in a controlled study with a study population of 662 people, showed that a combination of CS, celecoxib and glucosamine does not have any effects on OA signs. Unlike them, Zegels et al. 40 showed that CS alone was effective in reducing pain and OA signs. However, their followup time was 3 months and their study population was lower (353 patients) than those of Sawitzke et al. 36 . Dosage of CS in these two studies was the same, but Sawitzke et al. 36 administered the combination of CS, glucosamine and celecoxib. This combination may affect the effectiveness of CS in their study. However, further investigations are needed to prove if CS is effective in osteoarthrosis (Table 4) .
Discussion
The authors have referenced some of their own studies in this review. These referenced studies have been conducted in accordance with the Declaration of Helsinki (1964) , and the protocols of these studies have been approved by the relevant ethics committees related to the institution in which they were performed. All human subjects, in these referenced studies, gave informed consent to participate in these studies. Animal care was in accordance with the institution guidelines.
The present review clearly showed HA and CS as major glycosaminoglycans of the synovial fluid that are effective in treating many tissue injuries. We have reviewed many basic to clinical studies and showed the potential mechanisms of these two glycosaminoglycans in tissue healing. Despite the few controversies existing between the studies, majority of the studies approved their effectiveness in tissue healing 68, 77, 89 ( Tables 1-4) .
Here the major mechanisms of action of HA on wound healing are discussed to clarify why it is effective in the healing of different tissues. Several studies have stated that HA reduces peritendinous adhesion 20, 72, 74, 75, 79 . Based on the results of the previous in vitro and in vivo studies, HA reduces peritendinous adhesion by three different mechanisms (Tables  1-3) . First, HA has been shown to reduce proliferation of tenoblasts and fibroblasts both in vitro and in vivo 20, 25, 28, 30, 72, 74, 75, 79 (Tables 1-3) . Second, HA has some viscoelastic characteristics and can act as a barrier for the invading fibroblasts, and also by this characteristic it reduces the friction forces between the injured area and surrounding tissues. Finally, HA has been shown to modulate the inflammatory reaction after tendon injury 6, 7, 23, 29, 49 . During tendon healing, the inflammatory phase occurs and the proinflammatory cytokines together with the macrophages, neutrophils and lymphocytes initiate the fibroplasia 1, 2 . This implies that the mesenchymal cells proliferate, migrate and differentiate in the injured area 1 . During the proliferation phase, the fibroblasts may invade from the injured area to peritendinous tissues 1 .
In such instances, the invading fibroblasts start to produce collagen matrix in the peritendinous area, and this collagen matrix is going to be organized by time 1 . This reduces tendon movability and therefore lower forces are transmitted throughout the tendon proper 1, 3, [6] [7] [8] [9] [10] . This decreases the alignment and maturation of the collagen fibres and reduces the integrity of the healing tissue 1 . HA decreases the proliferation of invading fibroblasts in the peritendinous area, reduces the severity of inflammation and therefore initiates a less aggressive fibroplasia because it modulates the inflammatory phase of tendon healing. In fact, it acts as a barrier for the injured area and does not let the migrating fibroblasts invade from the injured area to the peritendinous area 6, 7 . The viscoelastic characteristic of HA reduces the friction forces between the injured area and peritendinous tissues and lets the healing tendon to be mobile in its space 6, 21, 31 . Therefore, the patient can use its injured area, and this lets the forces properly transmit throughout the injured area 1 . These forces have a role in tendon alignment and reduce the possibility of adhesion formation [6] [7] [8] [9] [10] . A healing tissue with lower adhesion to the surrounding tissues and aligned architecture has superior biomechanical characteristics and functionality compared with the healing tissues that have severe adhesion [7] [8] [9] [10] . The mechanism of action of HA in the cartilage is quite different from tendons and ligaments. HA has shown an increase in chondrogenesis and mesenchymal cell differentiation both in vitro and in vivo 17, 62 . HA has shown to suppress the PGE2 and IL-1 and some other proinflammatory cytokines and matrix metalloproteinases 46, 48 . It has also been reported that HA can increase collagen production by chondrocytes 19, 34 . Therefore, it seems that HA improves the osteoarthritis signs in human patients that are clinically ill 16, [88] [89] [90] [91] [92] ( Table 4 ). In addition, the role of viscoelastic characteristics of HA in osteoarthritis should be highlighted. By this effect, HA acts as a barrier for sheering forces in the articular cartilage and reduces the wear and tear that results in the reduction of the progression of osteoarthritis in clinically ill patients 16, [88] [89] [90] [91] [92] . CS is the major glycosaminoglycan of cartilage 36, 40 . It seems it has a role to rebuild the injured cartilage and together with the effectiveness of HA on osteoarthrosis may make a combination, which is effective in reduced osteoarthrosis progress. However, this should be confirmed in future studies. CS has many beneficial roles 36, 40 . For example, it collaborates in collagen production and maturation during tissue healing. It modulates inflammation and accelerates cell migration, proliferation and differentiation 6, [37] [38] [39] . By these mechanisms, it seems CS can be considered as an effective healing promotive factor; however most of the commercially available CS in the market are oral capsules. The major limitation of this model of drug delivery is its low availability and effectiveness in the site of injury 36, 40 . In addition, the injectable commercially available CS is more expensive than HA and its indication is in doubt. It seems that synovial fluid could be a better substitute than such injectable CS.
Both HA and CS have some roles in bone healing. The mechanisms of their effectiveness are similar to those described for other tissues; however, it seems that in addition to their modulatory effects on inflammation and cell behaviour, they also have some roles in bone remodelling by regulating osteoblast and osteoclast activity. They also have some roles in collagen production, matrix deposition and osteointegration (see Tables 1-4) .
Both HA and CS are safe and are well tolerated by humans and animals 6, 7, 36, 40, 82 . There are two critical points that should be highlighted. In the first step, the HA has three forms based on its molecular weight, including low-, medium-and highmolecular-weight varieties ( Tables  1-4) . Most in vitro, animal and human studies have suggested that the high-molecular-weight form of HA is more effective than the low or moderate ones (Tables 1-4) . Second, oral administration of the CS is not a drug but is considered as a supplement, and therefore higher doses and long usage time are needed to be effective. For example, it seems that CS supplementation of more than 1 or 2 years is needed to relieve the signs of clinically ill patients presented with osteoarthritis 36 . Based on these two points, it seems logical to use highmolecular-weight HA and injectable forms of CS as a new treatment modality in the healing of soft and hard connective tissues 6 . Such a combination naturally exists and as we have introduced, synovial fluid has both of them in its structure 18 . Researches on the role of exogenous synovial fluid are rare, and this could be a new area of interest in future investigations; however before testing, some important issues exist that should be addressed.
The exogenous synovial fluid could be obtained from different species, for example, in a patient with knee osteoarthritis in one leg; the other knee could be potentially considered as a donor site (autograft) [17] [18] [19] . The allograft or a xenograft form of synovial fluid could also be obtained from human and different species of animals, respectively [17] [18] [19] . For the allograft or xenograft synovial fluid, some concerns exist that should be solved before application. By performing some processing methods, we should provide safety and sterility of the product before administration 11 . Collecting a normal synovial fluid is the first issue because the OA or septic synovial fluid contains many proinflammatory cytokines and matrix metalloproteinases that may have destructive effects on the injured area [17] [18] [19] . The allo-and xenogeneic-based synovial fluid has cellular elements that are immunogenic for the host immune response 2, 11 . By administration of the intact allo-or xenogeneic-based synovial fluid in the injured area, the inflammatory cells invade the exogenous synovial cells and deliver large amounts of destructive enzymes in the injured area 2 . Therefore, the exogenous synovial fluid should be free of cells by acellularization process, using centrifugation technology 1, 2 . This is a simple method and is not expensive but seems to be effective in reducing immunogenic parts of the synovial fluid. The third issue is the sterility of the sample. This step could be accomplished by several technologies such as ultraviolet irradiation, alcohol preservation or adding antibiotics to the sample. However, this issue should be discussed in a more specific scientific report.
To the knowledge and experience of the authors, the most reliable and accessible source for the synovial fluid collection is bovine articular cartilage. Actually bovine has a large amount of synovial fluid in their articular space, which could be easily collected and stored in a refrigerator before possessing and application. This is the possible unfailing source and has many economic and clinical values in the near future.
Synovial fluid, HA, lubricin and CS can be designed in different formats. For example, they can be fabricated as a gel, solution, scaffold, vehicle, barrier, film, etc. 94 . These excellent physical characteristics are very important in medical application, and this makes their usage appealing in the near future.
Conclusion
Glycosaminoglycans such as HA and CS are the major effective constituents of synovial fluid. This study clearly showed that these glycosaminoglycans are effective in many different tissues, such as bone, tendon, ligament and cartilage. Most of the basic to clinical results suggest that administration of these glycosaminoglycans, particularly HA, has beneficial effects in reducing peritendinous adhesion and signs of osteoarthrosis and in improving bone tunnel healing, tendon and bone regeneration. It seems that exogenous synovial fluid may be a valuable option and is a less expensive way to provide such glycosaminoglycans in the site of injury. However, some modifications are necessary before its usage. Future studies should better clarify if synovial fluid is effective as HA and CS.
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